Insider · CIK 0001559827
Florence Anthony A. Jr.
Reports to the SEC for 52 companies · NEW YORK, NY
Transactions
50
Companies
52
Filings
4
CIK
0001559827
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-03-10 | KRROKorro Bio, Inc.P Purchase | +$2.3M |
| 2026-03-10 | KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase | +$2.7M |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series A Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.P Purchase | +$15M |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$3,719.25 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$1,240.85 |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$1,228.5 |
| 2025-10-02 | NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$16.6K |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$1,861.28 |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$4,342.97 |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$1,863 |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$6,075.36 |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$6,075 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$16.6K |
| 2025-10-02 | NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$4,340.25 |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$3,722.55 |
Recent filings
- 4Florence Anthony A. Jr.0001193125-26-104712SEC(opens sec.gov)
- 5Florence Anthony A. Jr.0001193125-26-051530SEC(opens sec.gov)
- 4Florence Anthony A. Jr.0001193125-26-046674SEC(opens sec.gov)
- 4Florence Anthony A. Jr.0001193125-25-232145SEC(opens sec.gov)
Companies
- Achaogen, Inc.10% Owner
- Adaptimmune Therapeutics PLC10% OwnerADAP
- Akouos, Inc.10% Owner
- Annexon, Inc.10% OwnerANNX
- APPIAN CORP10% OwnerAPPN
- Arcellx, Inc.10% Owner
- ARDELYX, INC.10% OwnerARDX
- Avalo Therapeutics, Inc.10% OwnerAVTX
- AVEO PHARMACEUTICALS, INC.10% Owner
- Berkshire Grey, Inc.10% Owner
- Black Diamond Therapeutics, Inc.10% OwnerBDTX
- Care.com IncDirector
- Cascadian Therapeutics, Inc.10% Owner
- Casper Sleep Inc.Director, 10% Owner
- CHAMPIONS ONCOLOGY, INC.10% OwnerCSBR
- CVENT INCDirector
- Desktop Metal, Inc.10% Owner
- Eargo, Inc.10% Owner
- Enliven Therapeutics, Inc.10% OwnerELVN
- Galera Therapeutics, Inc.10% OwnerGRTX
- GENOCEA BIOSCIENCES, INC.10% Owner
- Inozyme Pharma, Inc.10% Owner
- INTERLEUKIN GENETICS INC10% Owner
- IonQ, Inc.10% OwnerIONQ
- Korro Bio, Inc.10% OwnerKRRO
- Loxo Oncology, Inc.10% Owner
- Marker Therapeutics, Inc.10% OwnerMRKR
- MBX Biosciences, Inc.10% OwnerMBX
- Mersana Therapeutics, Inc.10% OwnerMRSN
- Metacrine, Inc.10% Owner
- Mirum Pharmaceuticals, Inc.10% OwnerMIRM
- Monte Rosa Therapeutics, Inc.10% OwnerGLUE
- MULESOFT, INC10% Owner
- NeueHealth, Inc.Director, 10% OwnerNEUE
- Nightstar Therapeutics plc10% Owner
- Nkarta, Inc.10% OwnerNKTX
- OnKure Therapeutics, Inc.10% OwnerOKUR
- Oruka Therapeutics, Inc.10% OwnerORKA
- Oyster Point Pharma, Inc.10% Owner
- Regulus Therapeutics Inc.Former 10% Owner
- Robinhood Markets, Inc.DirectorHOOD
- Savara Inc10% OwnerSVRA
- Senti Biosciences Holdings, Inc.10% OwnerSNTI
- SpyGlass Pharma, Inc.10% OwnerSGP
- Surface Oncology, Inc.10% Owner
- SYNLOGIC, INC.Director, 10% OwnerSYBX
- Tempest Therapeutics, Inc.10% OwnerTPST
- Tracon Pharmaceuticals, Inc.10% Owner
- Trevi Therapeutics, Inc.10% OwnerTRVI
- Verona Pharma plc10% OwnerVRNA
- X4 Pharmaceuticals, Inc10% OwnerXFOR
- ZeroFox Holdings, Inc.10% Owner
Address
104 5TH AVE 19TH FLOOR
NEW YORK, NY, 10011